ES2192419T3 - Material aislado que presenta un efecto anti-organotrofico. - Google Patents
Material aislado que presenta un efecto anti-organotrofico.Info
- Publication number
- ES2192419T3 ES2192419T3 ES99972922T ES99972922T ES2192419T3 ES 2192419 T3 ES2192419 T3 ES 2192419T3 ES 99972922 T ES99972922 T ES 99972922T ES 99972922 T ES99972922 T ES 99972922T ES 2192419 T3 ES2192419 T3 ES 2192419T3
- Authority
- ES
- Spain
- Prior art keywords
- organotrophic
- presents
- effect
- isolated material
- mammalian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Peptides Or Proteins (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Material que tiene la capacidad de reducir la masa de órganos, pudiéndose obtener dicho material mediante: la recogida de sangre venosa de ovario a partir de un mamífero hembra; la preparación de plasma venoso de ovario a partir de la sangre; y la purificación, por lo menos parcial, de dicho material a partir del plasma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9826186.0A GB9826186D0 (en) | 1998-12-01 | 1998-12-01 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2192419T3 true ES2192419T3 (es) | 2003-10-01 |
Family
ID=10843297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99972922T Expired - Lifetime ES2192419T3 (es) | 1998-12-01 | 1999-12-01 | Material aislado que presenta un efecto anti-organotrofico. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7572465B1 (es) |
| EP (1) | EP1135145B1 (es) |
| JP (1) | JP2002531410A (es) |
| AT (1) | ATE235910T1 (es) |
| AU (1) | AU758592B2 (es) |
| CA (1) | CA2353590A1 (es) |
| DE (1) | DE69906575T2 (es) |
| DK (1) | DK1135145T3 (es) |
| ES (1) | ES2192419T3 (es) |
| GB (1) | GB9826186D0 (es) |
| NZ (1) | NZ512123A (es) |
| PT (1) | PT1135145E (es) |
| WO (1) | WO2000032208A2 (es) |
| ZA (1) | ZA200104487B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0014029D0 (en) * | 2000-06-08 | 2000-08-02 | Endocrine Pharmaceuticals Limi | Isolated material having size-inhibitory effects on cells,tissues and organs |
| US8367801B2 (en) | 2008-01-10 | 2013-02-05 | Endocrine Pharmaceuticals Limited | Proteinaceous compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734398A (en) * | 1983-03-15 | 1988-03-29 | University Of Southern California | Follicular regulating protein |
-
1998
- 1998-12-01 GB GBGB9826186.0A patent/GB9826186D0/en not_active Ceased
-
1999
- 1999-12-01 EP EP99972922A patent/EP1135145B1/en not_active Expired - Lifetime
- 1999-12-01 PT PT99972922T patent/PT1135145E/pt unknown
- 1999-12-01 CA CA002353590A patent/CA2353590A1/en not_active Abandoned
- 1999-12-01 AT AT99972922T patent/ATE235910T1/de not_active IP Right Cessation
- 1999-12-01 WO PCT/GB1999/004013 patent/WO2000032208A2/en active IP Right Grant
- 1999-12-01 US US09/856,944 patent/US7572465B1/en not_active Expired - Fee Related
- 1999-12-01 ES ES99972922T patent/ES2192419T3/es not_active Expired - Lifetime
- 1999-12-01 AU AU13995/00A patent/AU758592B2/en not_active Ceased
- 1999-12-01 JP JP2000584903A patent/JP2002531410A/ja active Pending
- 1999-12-01 DK DK99972922T patent/DK1135145T3/da active
- 1999-12-01 NZ NZ512123A patent/NZ512123A/xx unknown
- 1999-12-01 DE DE69906575T patent/DE69906575T2/de not_active Expired - Lifetime
-
2001
- 2001-05-31 ZA ZA200104487A patent/ZA200104487B/en unknown
-
2005
- 2005-06-30 US US11/170,959 patent/US7700132B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200104487B (en) | 2002-07-25 |
| WO2000032208A3 (en) | 2000-10-19 |
| EP1135145B1 (en) | 2003-04-02 |
| EP1135145A2 (en) | 2001-09-26 |
| AU758592B2 (en) | 2003-03-27 |
| PT1135145E (pt) | 2003-07-31 |
| US20050244507A1 (en) | 2005-11-03 |
| ATE235910T1 (de) | 2003-04-15 |
| DK1135145T3 (da) | 2003-06-23 |
| US7700132B2 (en) | 2010-04-20 |
| DE69906575D1 (de) | 2003-05-08 |
| JP2002531410A (ja) | 2002-09-24 |
| US7572465B1 (en) | 2009-08-11 |
| GB9826186D0 (en) | 1999-01-20 |
| AU1399500A (en) | 2000-06-19 |
| CA2353590A1 (en) | 2000-06-08 |
| DE69906575T2 (de) | 2003-12-11 |
| WO2000032208A2 (en) | 2000-06-08 |
| NZ512123A (en) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT695758E (pt) | Amidas e esteres de pentapeptidos inibidores de cancro humano | |
| EP1955700A3 (en) | Therapeutic treatment of androgen receptor driven conditions | |
| DE60019122D1 (de) | Veränderter faktor viii | |
| DE29600939U1 (de) | Vorrichtung zur Bauchspiegelung oder zur Extraktion von Organen oder Organteilen | |
| YU46097A (sh) | Nova klasa estara i njihove farmaceutske smeše | |
| ATE177421T1 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
| DE69412807D1 (de) | Einrichtung zur abgabe von elektrischen impulsen für die behandlung biologischer gewebe | |
| ATE382630T1 (de) | Moleküle, die sich in ausgewählten organen oder geweben in-vivo einfinden | |
| ATE466072T1 (de) | Bandscheibe | |
| CA2169381A1 (en) | Enhanced cross-linking of natural tissues | |
| DE69527749T2 (de) | Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen | |
| DE69901569D1 (de) | Humane antikörper gegen faktor ix/ixa | |
| BR0010314A (pt) | Solução aquosa de conservação de tecidos e órgãos | |
| NO982721L (no) | Preserverende oppl°sning | |
| CA2212563A1 (en) | Process for obtaining medically active fractions from sea cucumbers | |
| EE200000163A (et) | Protsess kirurgiliste instrumentide puhastamiseks | |
| ES2192419T3 (es) | Material aislado que presenta un efecto anti-organotrofico. | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| MXPA02005069A (es) | Agentes de enlace especificos para t3 y metodos para su uso. | |
| DE9404106U1 (de) | Vorrichtung zur gezielten Heilbehandlung von erkrankten Zellen, Organen, Geweben o.dgl. | |
| ATE42201T1 (de) | Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt. | |
| ATE256485T1 (de) | Magnetotherapeutische vorrichtung | |
| ATE320263T1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| ATE306929T1 (de) | Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden | |
| ATE313329T1 (de) | Disaccharidderivate zur behandlung von hyperglykämien |